Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP blocks with Nimbus Infusion in breast reconstruction
NCT02601027Phase 3Completed
- Sponsor
- Stanford University
- Start
- Nov 2015
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Stanford University. Started Nov 2015; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02601027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601027.